Additionally, retinal αSyn pathology was also observed in cases with mixed pathology (OR = 25.0, P = 0.041) and in one FTLD-tau case (#58), all having moderate to advanced stages of synucleinopathy (Braak LB stage ≥ 3). The gene discussed is MAPT; the disease is synucleinopathy.